Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bayer AG

Start price
Target price
Perf. (%)
€26.78
11.03.24
€28.00
11.03.25
6.63%
28.03.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Bayer AG

Start price
Target price
Perf. (%)
€32.77
24.11.23
€35.00
21.12.23
-6.78%
29.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Bayer AG

Start price
Target price
Perf. (%)
€40.83
15.11.23
€35.00
15.11.24
-19.02%
22.11.23

Probably not worthwhile Investment
Higher risks for its business
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€18.69
12.06.22
€28.00
12.06.23
53.93%
13.06.23

Could be worthwhile Investment >10% per year
Merck KGaA

Start price
Target price
Perf. (%)
€190.20
23.01.23
€175.00
23.04.23
-12.41%
23.04.23

Some uniques
Future proof or reliable business model
overvalued
Low dividend yield expected
buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
13.11.22
€3.00
13.11.23
-0.60%
26.11.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
buy
Bayer AG

Start price
Target price
Perf. (%)
€43.96
06.12.21
€48.00
12.10.22
12.32%
13.10.22

Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
07.05.21
€60.00
07.05.22
-37.42%
08.05.22

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€81.20
03.05.21
€75.00
03.05.22
-41.82%
04.05.22

Could be worthwhile Investment >10% per year
Sartorius AG VZO

Start price
Target price
Perf. (%)
€468.70
16.04.21
€440.00
16.04.22
-18.50%
17.04.22

Probably not worthwhile Investment
Very low/no dividend yield expected
buy
Stratec SE

Start price
Target price
Perf. (%)
€122.40
30.12.20
€128.00
30.12.21
12.75%
31.12.21

Could be worthwhile Investment >10% per year
Bayer AG

Start price
Target price
Perf. (%)
€47.84
12.10.21
€45.00
12.10.22
-8.10%
06.12.21

Could be worthwhile Investment >10% per year
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€2.68
16.03.20
€3.00
04.11.21
120.15%
05.11.21

Could be worthwhile Investment >10% per year
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€1.50
12.03.20
€2.50
04.11.21
270.67%
05.11.21

Could be worthwhile Investment >10% per year
buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€101.30
10.08.19
€169.00
04.11.21
83.17%
05.11.21

buy
Evotec SE

Start price
Target price
Perf. (%)
€19.10
15.08.19
€35.00
04.11.21
105.76%
05.11.21

buy
Merck KGaA

Start price
Target price
Perf. (%)
€95.46
03.07.19
€129.00
04.11.21
128.05%
05.11.21

buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€67.50
27.07.18
€110.00
04.11.21
174.89%
05.11.21

buy
Merck KGaA

Start price
Target price
Perf. (%)
€82.56
20.06.18
€149.00
04.11.21
163.69%
05.11.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.41
09.11.20
€40.00
09.11.21
18.27%
02.11.21

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Merck KGaA

Start price
Target price
Perf. (%)
€144.55
11.01.21
€145.00
11.01.22
42.10%
12.09.21

Could be very worthwhile Investment >20% year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.83
08.02.21
€41.00
16.07.21
27.92%
16.07.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.43
23.09.20
€36.00
04.11.21
58.26%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.22
14.10.20
€47.00
04.11.21
8.47%
11.11.20

Undervalued
Risky Investment
buy
Bayer AG

Start price
Target price
Perf. (%)
€57.94
24.03.19
€67.00
09.08.19
22.20%
09.08.19

Could be worthwhile Investment >10% per year